Showing results (481-490 of 591) with videos related to
Sort By:
Pageof 60
European Journal of Immunology|September 16, 2004
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragmentsGerhard Held, Mitsutoshi Matsuo, Malka Epel, et al.Cancer Immunity|February 8, 2013
SurfaceomeDB: a cancer-orientated database for genes encoding cell surface proteinsJorge Estefano Santana de Souza, Pedro Alexandre Favoretto Galante, Renan Valieris Bueno de Almeida, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remissionCatherine S M Diefenbach, Sacha Gnjatic, Paul Sabbatini, et al.Proceedings of the National Academy of Sciences of the United States of America|August 21, 2002
CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patientsSacha Gnjatic, Elke Jäger, Weisan Chen, et al.International Journal of Oncology|February 10, 1998
Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude miceE C Barendswaard, A M Scott, C R Divgi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1Hilary A Vaughan, Suzanne Svobodova, Duncan Macgregor, et al.Cancer Immunity|November 2, 2004
Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancerYu Wang, Xiao-Jiang Wu, Ai-Lian Zhao, et al.Cancer Immunology, Immunotherapy : CII|May 24, 2006
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patientsAlfred Zippelius, Asma Gati, Tammo Bartnick, et al.Cancer Immunology, Immunotherapy : CII|April 6, 2011
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three casesJianda Yuan, Brian Ginsberg, David Page, et al.Cancer Immunity|November 7, 2007
PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responsesWilson A Silva, Sacha Gnjatic, Erika Ritter, et al.Pageof 60